This paper presents results from the third year of a multiyear, pre-committed research design for analyzing recent minimum wage changes.

The likely impact of the COVID-19 pandemic on state and local government revenues is increasingly well understood.

Clemens and Strain present early evidence on the employment effects of state minimum wage increases enacted between January 2013 and January 2015 and offer an interpretative framework to understand why it is of interest to study recent changes in isolation.

Why do individuals join interest groups?

This paper presents a data set that tracks effective minimum wage rates across the US states, including the District of Columbia, from January 1, 2011, to January 1, 2018.

We assess the Covid-19 pandemic's implications for state government sales and income tax revenues. We estimate that the economic declines implied by recent forecasts from the Congressional Budget Office will lead to a shortfall of roughly $106 billion in states' sales and income tax revenues for...

COVID-19 relief legislation offers a unique setting to study how political representation shapes the distribution of federal assistance to state and local governments. We provide evidence of a substantial small-state bias: an additional Senator or Representative per million residents predicts an...

We describe the broad range of uncertainties faced by the developers of medical technologies. Empirically, we estimate the asset market incidence of two realizations of uncertainties we classify as within-market policy risks. The events we analyze concern the intellectual property of Myriad...

Empirical research on minimum wages has historically focused on employment effects, with the implicit assumption that workers who remain employed under a minimum wage regime are better off. This paper develops a simple model and a stylized example to highlight the importance of an...

We describe the broad range of uncertainties faced by the developers of medical technologies. Empirically, we estimate the asset market incidence of the realization  of two such of uncertainties experienced by the biotechnology firm Myriad Genetics, Inc.